The use of susceptibility-weighted imaging to detect cerebral microbleeds after lacunar infarction

L Shao1, M Wang, X-H Ge

  • 1Internal Medicine-Neurology, Xuzhou First Hospital, Xuzhou, Jiangsu, China. gexuhuaxzyy@aliyun.com.

Abstract

Insights

Susceptibility-weighted imaging (SWI) is highly sensitive for detecting cerebral microbleeds (CMBs) in patients with lacunar infarction. Treatment with antiplatelet or anticoagulant therapy showed a relatively smaller risk of cerebral hemorrhagic transformation within 12 months.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Cerebral microbleeds (CMBs) are common in senile cerebral lacunar infarction.
  • Detecting CMBs is crucial for assessing hemorrhage risk.
  • Conventional MRI sequences have limitations in detecting CMBs.

Purpose of the Study:

  • To evaluate the diagnostic value of susceptibility-weighted imaging (SWI) for detecting CMBs in patients with lacunar infarction.
  • To assess the risk of cerebral hemorrhage transformation in patients with CMBs receiving antiplatelet or anticoagulant therapy.

Main Methods:

  • MRI scans including GRE-T2*WI, SWI, and FSE sequences were performed on 180 patients (60 per group: lacunar infarction, lacunar infarction with CMBs, healthy elderly).
  • Patients with lacunar infarction received antiplatelet or anticoagulant therapy.
  • Follow-up for 12 months to observe cerebral hemorrhages and post-event effects.

Main Results:

  • SWI demonstrated the highest positive rate for CMB detection, significantly higher than GRE-T2*WI and conventional sequences (p < 0.05).
  • Lacunar infarction patients had a significantly higher prevalence and severity of CMBs compared to the healthy elderly group (p < 0.05).
  • Only one case of cerebral hemorrhage occurred in the CMBs group receiving therapy, with no statistical significance (p > 0.05).

Conclusions:

  • SWI is a highly sensitive and specific tool for diagnosing CMBs in lacunar infarction.
  • GRE-T2*WI is more sensitive than conventional FSE sequences for CMB detection.
  • Antiplatelet and anticoagulant therapy in patients with CMBs may reduce the risk of cerebral hemorrhagic transformation within 12 months, warranting further long-term observation.

Related Concept Videos